• Product nameAnti-TCF7L2 antibody
    See all TCF7L2 primary antibodies
  • Description
    Mouse monoclonal to TCF7L2
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant full length protein, corresponding to amino acids 1-456 of Human TCF7L2



Our Abpromise guarantee covers the use of ab57679 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesWB: Use at a concentration of 1-5 µg/ml.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionParticipates in the Wnt signaling pathway and modulates MYC expression by binding to its promoter in a sequence-specific manner. Acts as repressor in the absence of CTNNB1, and as activator in its presence. Activates transcription from promoters with several copies of the Tcf motif 5'-CCTTTGATC-3' in the presence of CTNNB1. TLE1, TLE2, TLE3 and TLE4 repress transactivation mediated by TCF7L2 and CTNNB1. Expression of dominant-negative mutants results in cell-cycle arrest in G1. Necessary for the maintenance of the epithelial stem-cell compartment of the small intestine.
    • Tissue specificityDetected in epithelium from small intestine, with the highest expression at the top of the crypts and a gradient of expression from crypt to villus. Detected in colon epithelium and colon cancer, and in epithelium from mammary gland and carcinomas derived therefrom.
    • Involvement in diseaseNote=Constitutive activation and subsequent transactivation of target genes may lead to the maintenance of stem-cell characteristics (cycling and longevity) in cells that should normally undergo terminal differentiation and constitute the primary transforming event in colorectal cancer (CRC).
      Genetic variations in TCF7L2 are associated with susceptibility to non-insulin-dependent diabetes mellitus (NIDDM) [MIM:125853]. NIDDM is characterized by an autosomal dominant mode of inheritance, onset during adulthood and insulin resistance.
    • Sequence similaritiesBelongs to the TCF/LEF family.
      Contains 1 HMG box DNA-binding domain.
    • Developmental stageHighly expressed in crypt regions and barely detectable in villi in epithelium from fetal small intestine at week 16. At week 22 expression in villi had increased strongly.
    • DomainThe promoter-specific activation domain interacts with the transcriptional coactivator EP300.
    • Post-translational
      In vitro, phosphorylated by TNIK.
      Polysumoylated. Sumoylation is enhanced by PIAS family members and desumoylated by AXAM/SENP2. Sumoylation/desumoylation regulates TCF4 transcription activity in the Wnt signaling pathway without altering interaction with CTNNB1 nor binding DNA.
    • Cellular localizationNucleus > PML body. Diffuse pattern. Colocalizes with SUMO1 and PIAS4 in a subset of PML (promyelocytic leukemia) nuclear bodies.
    • Information by UniProt
    • Database links
    • Alternative names
      • HMG box transcription factor 4 antibody
      • hTCF 4 antibody
      • hTCF-4 antibody
      • T cell factor 4 antibody
      • T cell specific HMG box antibody
      • T cell specific transcription factor 4 antibody
      • T-cell factor 4 antibody
      • T-cell-specific transcription factor 4 antibody
      • TCF 4 antibody
      • TCF-4 antibody
      • TCF4 antibody
      • TCF7L2 antibody
      • TCF7L2 protein antibody
      • TF7L2_HUMAN antibody
      • Transcription factor 7 like 2 antibody
      • Transcription factor 7 like 2 T cell specific HMG box antibody
      • Transcription factor 7-like 2 antibody
      see all

    Anti-TCF7L2 antibody images

    • Predicted band size : 68 kDa

    References for Anti-TCF7L2 antibody (ab57679)

    ab57679 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab57679.
    Please use the links above to contact us or submit feedback about this product.